FDA Approved: SERNIVO — Original Application (Primus Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved SERNIVO (betamethasone dipropionate) from Primus Pharmaceuticals in an original NDA for the topical treatment of plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• SERNIVO (Betamethasone dipropionate)

Snippet

ORIG AP for SERNIVO (BETAMETHASONE DIPROPIONATE)